A study has shown that the combined inhibition of Aurora B kinase and EGFR prevents and eliminates the resistance to EGFR inhibitors in lung cancer by promoting BIM and PUMA-mediated apoptosis [132]. The gene discussed is BCL2L11; the disease is lung carcinoma.